• Nenhum resultado encontrado

Arq. Bras. Cardiol. vol.86 número5

N/A
N/A
Protected

Academic year: 2018

Share "Arq. Bras. Cardiol. vol.86 número5"

Copied!
1
0
0

Texto

(1)

Arquivos Brasileiros de Cardiologia - Volume 86, Nº 5, May 2006

Letters to the Editor

Mailing Address: Mauricio Scanavacca • InCor - Av. Dr. Enéas de Carvalho Aguiar, 44 - 05403-000 – São Paulo, SP - Brazil E-mail: mauricio.scanavacca@incor.usp.br Received on 03/24/06 • Accepted on 03/24/06

Symptoms-guided Assessment of Atrial Fibrillation

Recurrence After Radiofrequency Pulmonary Vein

Ablation: is it a Reliable Strategy?

Mauricio Scanavacca e Eduardo Sosa

Instituto do Coração do Hospital das Clínicas – FMUSP - São Paulo, SP - Brazil

Dear Editor,

With respect to the article “Catheter Ablation of Atrial Fibrillation – Techniques and Results”, published in the October 2005 edition (Arq Bras Cardiol. 2005;85:295-301), the issues raised by our colleagues Paulo Roberto Benchimol Barbosa and José Barbosa Filho on the risk of asymptomatic recurrence of atrial fi brillation (AF) after catheter ablation are of great clinical relevance1.

Symptom-guided assessment, associated with 24-hour Holter monitoring, has been the strategy used by authors of the major published papers reporting the results of catheter ablation of AF2,3. In studies using

long-term rhythm monitoring through seven-day Holter or daily transtelephonic ECG transmissions, the number of recurrences in asymptomatic patients was found to be signifi cantly higher4,5. The use of a more sensitive

method to establish the actual success rate of AF ablation procedures is not only desirable, but also the cornerstone of the decision regarding anticoagulation therapy discontinuation, taking into account the risk of embolic events. Thus, daily transtelephonic monitoring during one year has already been used by the latest scientifi c studies for a more reliable evaluation of AF ablation

effectiveness6,7. However, this monitoring strategy with

daily sampling of heart rhythm is not practical for long-term use. In addition, it has some limitations regarding recurrence evaluation, since it provides intermittent recording, and asymptomatic and self-limited episodes may be missed.

In our opinion, the choice of a method to evaluate success depends on the patient’s clinical characteristics. In young, symptomatic subjects with paroxysmal atrial fi brillation but no risk factors for embolic phenomena, in which the procedure is intended to improve quality of life, symptom-guided assessment associated with 24-hour Holter seems to be quite acceptable for clinical follow-up. Yet, this conduct is not appropriate for patients at high risk of embolism. Theoretically, in view of the limitations of the monitoring systems described above, these patients should be kept indefi nitely anticoagulated. An alternative would be continuous, long-term ECG monitoring over the years showing absence of atrial fi brillation. Currently, this monitoring system is available only in pacemakers with AF detection algorithm and implantable loop recorders, even though no prospective studies have been made showing either the effi cacy or cost-effectiveness of these technologies8,9.

R

EFERENCES

1. Barbosa PRB, Barbosa Filho J. Avaliação da Recidiva da Fibrilação Atrial após Ablação da Veia Pulmonar por Radiofreqüência Baseada em Sintomas: esta é uma Estratégia Confi ável? Arq Bras Cardiol 2006; 86: 396.

2. Pappone C, Oreto G, Rosanio S et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation. Circulation2001; 104: 2539.

3. Hocini M, Sanders P, Jais P et al. Techniques for curative treatment of atrial fi brillation.J Cardiovasc Electrophysiol 2004; 15: 1467-71.

4. Piorkowski C, Kottkamp H, Tanner H et al.Value of different follow-up strategies to assess the effi cacy of circumferential pulmonary vein ablation for the curative treatment of atrial fi brillation. J Cardiovasc Electrophysiol 2005; 16: 1286-92.

5. Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fi brillation

before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-13.

6. Verma A, Marrouche NF, Natale A. Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique. J Cardiovasc Electrophysiol 2004; 15: 1335-40.

7. Oral H, Pappone C, Chugh A et al.Circumferential pulmonary-vein ablation for chronic atrial fi brillation. N Engl J Med 2006; 354: 934-41.

8. Passman RS, Weinberg KM, Freher M et al. Accuracy of mode switch algorithms for detection of atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2004; 15: 773-7.

9. Montenero AS, Quayyum A, Franciosa P et al. Implantable loop recorders: a novel method to judge patient perception of atrial fibrillation. Preliminary results from a pilot study. J Interv Card Electrophysiol 2004; 10: 211-20.

Referências

Documentos relacionados

This study demonstrated that in elderly patients with stable coronary atherosclerosis, exercise-induced myocardial ischemia and minimal ventricular dysfunction, the heart rate at

Based on the exercise stress test results, it was found that exercise capacity of 39% of the men and 55% of the women was less than 6 METS, which points to a sedentary or

demonstrated improved endothelial function in insulin- resistant type-2 diabetics after 12 weeks of ROSI therapy. In this study, endothelial function improvement occurred Fig. 1 –

In the present study, a research related to the myocyte cell area with relation to its position in different heart coats was not carried out, but taking as reference the

Finally, it can stated that, in mild cases of pulmonary stenosis with a pressure gradient < 30 mmHg, diagnosed and evaluated at any age range, except neonatal and fi rst months

In the present paper, we analyzed the immediate results of percutaneous mitral balloon valvuloplasty in a group of patients that had undergone previous percu- taneous or

A chest helical CT revealed a dilation of the pulmonary artery and its main branches with a fi lling defect of the right main branch and a regular peripheral opacity of

A forty-one-year-old male with systolic heart failure, FC- III NYHA, clinical stage C due to dilated cardiomyopathy was submitted to an autologous transplant of the